Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder
Year: 2008
Type: article
Abstract: Major Depressive Disorder (MDD) is a prevalent illness that is frequently associated with significant disability, morbidity and mortality Despite the development and availability of numerous treatment options for MDD, studies have shown that antidepressant monotherapy yields only modest rates of response and remission. Clearly, there is an urgent need to develop more effective treatment strategies for patients with MDD. One possible approach towards the development of novel pharmacotherapeutic strategies for MDD involves identifying subpopulations of depressed patients who are more likely to experience the benefits of a given (existing) treatment versus placebo, or versus a second treatment. Attempts have been made to identify such "subpopulations", specifically by testing whether a given biological or clinical marker also serves as a moderator, mediator (correlate), or predictor of clinical improvement following the treatment of MDD with standard, first-line antidepressants. In the following article, we will attempt to summarize the literature focusing on several major areas ("leads") where preliminary evidence exists regarding clinical and biologic moderators, mediators, and predictors of symptom improvement in MDD. Such clinical leads will include the presence of hopelessness, anxious symptoms, or medical comorbidity. Biologic leads will include gene polymorphisms, brain metabolism, quantitative electroencephalography, loudness dependence of auditory evoked potentials, and functional brain asymmetry.
Authors: George I. Papakostas, Maurizio Fava
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: major depressive disorder, antidepressant treatment outcome, treatment moderators, predictors of treatment response, hopelessness, anxiety symptoms, comorbidities, genetic polymorphism, brain metabolism, quantitative EEG, loudness dependence of auditory evoked potentials, functional brain asymmetry
Open Access status: diamond
OpenAlex ID: W1759151863
